Late Breaking Science | AUA

J. Curtis Nickel, MD, FRCSC

Final results for sublingual UTI vaccine to be announced

These vaccines offer the potential for longer lasting prevention.

Toni K. Choueiri, MD

Pembrolizumab is first immunotherapy to show benefits in RCC adjuvant use

Getty Images 619392764

Check back during the event for our coverage of late-breaking science